Atlas Trials

Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

Clinical trial NCT01857544 · UNKNOWN

Trial details

NCT number
NCT01857544
Sponsor
Tennessee Retina
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Retinal Vein Occlusion
Start date
2013-06-01
Primary completion
2016-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.